Novartis Transderm Scop Superiority Claims To OTC In DTC Ads Disputed

Novartis Transderm Scop superiority claims in a direct-to-consumer ad campaign rely on the misappropriation of an Rx label statement to consumer advertising, the National Advertising Division of the Council of Better Business Bureaus indicated in a Nov. 8 decision.